LAUREN SOULES: Open Payments
NPI 1013398072 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 23 payments from 14 companies in 2025. Trend: 2023 $245 · 2024 $471 · 2025 $535
Food & beverage: $535
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $80 |
| Novartis Pharmaceuticals Corporation | 3 | $78 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $64 |
| Aveo Pharmaceuticals, Inc. | 2 | $48 |
| Daiichi Sankyo Inc. | 2 | $46 |
| Genmab U.S., Inc. | 2 | $44 |
| ABBVIE INC. | 1 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $24 |
| Exelixis Inc. | 1 | $22 |
Products named: ENHERTU, PLUVICTO, JOURNAVX, FOTIVDA, IMBRUVICA, LIBTAYO, Tivdak, NERLYNX.
Industry payments across NM — which companies pay providers there.
